Intuitive Surgical Inc. (ISRG) Given Outperform Rating at Wedbush
Intuitive Surgical Inc. (NASDAQ:ISRG)‘s stock had its “outperform” rating restated by investment analysts at Wedbush in a report issued on Wednesday. They presently have a $755.00 target price on the stock, down from their prior target price of $785.00. Wedbush’s price target would suggest a potential upside of 4.61% from the company’s current price.
Several other research firms also recently commented on ISRG. Evercore ISI reiterated a “buy” rating and set a $775.00 target price (up from $750.00) on shares of Intuitive Surgical in a research report on Wednesday, July 20th. Royal Bank Of Canada boosted their price target on shares of Intuitive Surgical from $750.00 to $760.00 and gave the stock a “sector perform” rating in a research report on Wednesday. Zacks Investment Research downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Tuesday, September 20th. Stifel Nicolaus boosted their price target on shares of Intuitive Surgical from $700.00 to $800.00 and gave the stock a “buy” rating in a research report on Wednesday, July 20th. Finally, Citigroup Inc. boosted their price target on shares of Intuitive Surgical from $723.00 to $779.00 and gave the stock a “buy” rating in a research report on Wednesday, July 20th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and fourteen have given a buy rating to the company. Intuitive Surgical presently has a consensus rating of “Buy” and an average target price of $710.82.
Intuitive Surgical (NASDAQ:ISRG) opened at 721.73 on Wednesday. Intuitive Surgical has a 52-week low of $483.11 and a 52-week high of $727.25. The company has a 50-day moving average of $703.09 and a 200-day moving average of $666.36. The company has a market cap of $27.78 billion, a P/E ratio of 40.96 and a beta of 0.72.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/19/intuitive-surgical-inc-isrg-given-outperform-rating-at-wedbush.html
Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 18th. The company reported $6.19 EPS for the quarter, topping the consensus estimate of $5.13 by $1.06. Intuitive Surgical had a net margin of 26.80% and a return on equity of 15.25%. The business had revenue of $682.90 million for the quarter, compared to the consensus estimate of $650.49 million. During the same period last year, the company earned $5.24 EPS. The firm’s revenue was up 15.8% compared to the same quarter last year. On average, equities research analysts expect that Intuitive Surgical will post $21.30 earnings per share for the current fiscal year.
In related news, Director Alan J. Levy sold 3,188 shares of the stock in a transaction dated Thursday, August 4th. The shares were sold at an average price of $694.11, for a total transaction of $2,212,822.68. Following the completion of the transaction, the director now owns 5,401 shares in the company, valued at $3,748,888.11. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Mark J. Meltzer sold 3,000 shares of the stock in a transaction dated Monday, August 22nd. The shares were sold at an average price of $688.33, for a total transaction of $2,064,990.00. Following the transaction, the senior vice president now owns 2,331 shares of the company’s stock, valued at approximately $1,604,497.23. The disclosure for this sale can be found here. 3.10% of the stock is currently owned by insiders.
A number of institutional investors have recently bought and sold shares of the stock. Stonebridge Capital Management Inc. bought a new position in Intuitive Surgical during the third quarter valued at $209,000. National Pension Service raised its position in Intuitive Surgical by 8.9% in the third quarter. National Pension Service now owns 26,826 shares of the company’s stock valued at $19,444,000 after buying an additional 2,199 shares during the last quarter. Forte Capital LLC ADV raised its position in Intuitive Surgical by 11.0% in the third quarter. Forte Capital LLC ADV now owns 1,619 shares of the company’s stock valued at $1,173,000 after buying an additional 160 shares during the last quarter. Gulf International Bank UK Ltd raised its position in Intuitive Surgical by 6.9% in the third quarter. Gulf International Bank UK Ltd now owns 11,790 shares of the company’s stock valued at $8,545,000 after buying an additional 760 shares during the last quarter. Finally, Nisa Investment Advisors LLC raised its position in Intuitive Surgical by 0.9% in the third quarter. Nisa Investment Advisors LLC now owns 9,547 shares of the company’s stock valued at $6,920,000 after buying an additional 81 shares during the last quarter. Institutional investors own 92.03% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.